XRTX · Company research
XORTX Therapeutics Inc. Common Stock (XRTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
12records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| XORTX Therapeutics Inc (NASDAQ: XRTX) Stock Price, News & Analysis - Kalkine | XORTX Therapeutics Inc (NASDAQ: XRTX) Stock Price, News & Analysis Kalkine | View source ↗ | Kalkine | Oct 12, 2026 | neutral | 0 | 0.6 |
| 12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga | 12 Health Care Stocks Moving In Friday's After-Market Session Benzinga | View source ↗ | Benzinga | Oct 9, 2026 | neutral | 0 | 0.6 |
| XRTX Stock Slides As Volatility Spikes And Cash Burn Deepens - StocksToTrade | XRTX Stock Slides As Volatility Spikes And Cash Burn Deepens StocksToTrade | View source ↗ | StocksToTrade | Oct 9, 2026 | neutral | 0 | 0.6 |
| XRTX Stock Jumps As Gout Drug Program Accelerates - StocksToTrade | XRTX Stock Jumps As Gout Drug Program Accelerates StocksToTrade | View source ↗ | StocksToTrade | Oct 9, 2026 | neutral | 0 | 0.6 |
| XORTX Therapeutics (XRTX) Stock Jumps Over 22% After Hours: Here's Why - Benzinga | XORTX Therapeutics (XRTX) Stock Jumps Over 22% After Hours: Here's Why Benzinga | View source ↗ | Benzinga | Oct 9, 2026 | neutral | 0 | 0.6 |
| Canadian testing is expected to speed data for XORTX (XRTX)'s planned U.S. gout drug application. - Stock Titan | Canadian testing is expected to speed data for XORTX (XRTX)'s planned U.S. gout drug application. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Global gout cases are expected to rise 70% over 25 years. XORTX plans to apply to study a gout drug in Canada. - Stock Titan | Global gout cases are expected to rise 70% over 25 years. XORTX plans to apply to study a gout drug in Canada. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| XORTX Therapeutics Inc (NASDAQ: XRTX) Stock Price, News & Analysis - kalkine.ca | XORTX Therapeutics Inc (NASDAQ: XRTX) Stock Price, News & Analysis kalkine.ca | View source ↗ | kalkine.ca | Oct 7, 2026 | neutral | 0 | 0.6 |
| XRTX Forecast — Price Target — Prediction for 2027 - TradingView | XRTX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Sep 30, 2026 | neutral | 0 | 0.6 |
| XORTX (XRTX) Stock Screener: -4.94% Decline on Elevated Volume 2026-09-17 - Unusual Call Volume - siam.in | XORTX (XRTX) Stock Screener: -4.94% Decline on Elevated Volume 2026-09-17 - Unusual Call Volume siam.in | View source ↗ | siam.in | Sep 17, 2026 | neutral | 0 | 0.6 |
| XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split | XRTX Stock News - Quiver Quantitative | XORTX Therapeutics jumps as it confirms Nasdaq bid-price compliance after reverse split | XRTX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 21, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 22, 2023 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.